The STUDIA UNIVERSITATIS BABEŞ-BOLYAI issue article summary

The summary of the selected article appears at the bottom of the page. In order to get back to the contents of the issue this article belongs to you have to access the link from the title. In order to see all the articles of the archive which have as author/co-author one of the authors mentioned below, you have to access the link from the author's name.

 
       
         
    STUDIA CHEMIA - Issue no. 4 / 2020  
         
  Article:   LIPIDOMICS: ADVANCED ANALYTICAL TECHNOLOGY TO IDENTIFY BIOMARKERS OF COLORECTAL CANCER.

Authors:  CLAUDIU RĂCHIERIU, DAN T. ENIU, EMIL MOIŞ, FLORIN GRAUR, CARMEN SOCACIU, MIHAI ADRIAN SOCACIU, NADIM ALHAJJAR.
 
       
         
  Abstract:  
DOI: 10.24193/subbchem.2020.4.15

Published Online: 2020-12-30
Published Print: 2020-12-30
pp. 203-215
VIEW PDF: FULL PDF

ABSTRACT: Lipidomics is an advanced analytical technology applying techniques like Gas- or Liquid Chromatography coupled with Mass Spectrometry or Magnetic Resonance Spectrometry to find the lipid biomarkers in tissues, blood or urine. This review selected significant results which show the impact of lipidomic investigations for discriminating the metabolic profiles and dysregulation of metabolic pathways in CRC patient’s comparative to healthy controls. It focuses on the description of best methods and procedures to separate and identify hydrophobic molecules with molecular weights under 1000 Daltons, especially using high pressure liquid chromatography coupled with mass spectrometry. The main lipid classes involved in the onset and progression of CRC are presented, as well the alterations of lipid-related cellular pathways during tumorigenesis. Especially lipid profile changes (of cerotic acid, hydroxylated, polyunsaturated fatty acids, free fatty acids, oxylipins, glycero¬phospholipids, di- and triglycerides, sphingomyelins and ceramides) showed significant differences and can be considered reliable biomarkers to discriminate between early and advanced stages of CTC malignancy, prognosis or survival prediction.

Key words: metabolomics, lipidomics, colorectal cancer, biomarkers.
 
         
     
         
         
      Back to previous page